Scrip Symbol
SUVEN
Suven Life Sciences Limited has made a regulatory disclosure regarding the allotment of equity shares under its employee stock option plan. The Nomination & Remuneration Committee of the company, in its meeting held on June 22, 2026, approved the allotment of 2,71,970 equity shares of ₹1 each issued at an exercise price of ₹55 per share (including a premium of ₹54 per share) to eligible employees. This allotment was made upon the exercise of vested stock options under the Suven Life Sciences Limited Employee Stock Option Scheme 2020 (SLSL ESOP 2020).
Capital Structure Impact
The allotment has resulted in an increase to the company's paid-up equity share capital:
- Pre-issue subscribed & paid-up capital: 26,37,20,583 equity shares amounting to ₹26,37,20,583.00
- Post-issue subscribed & paid-up capital: 26,39,92,553 equity shares amounting to ₹26,39,92,553.00
Share Details
The newly issued shares have the following characteristics:
- Par value: ₹1 per share
- Distinctive numbers: 26,37,20,584 to 26,39,92,553
- The shares rank pari-passu with existing shares in all respects
- No lock-in restrictions apply to these shares
Financial Details
- Total money realized by exercise of options: ₹1,49,58,350
- Number of options exercised: 2,71,970
Additional Information
The scheme is in compliance with SEBI (SBEB) Regulations, 2021. The company's shares are listed on both BSE Limited and National Stock Exchange of India Limited. The original statement for the ESOP scheme was filed with the exchanges on December 03, 2020.